...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
【24h】

Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.

机译:新型2,4,6-三取代嘧啶和1,3,5-三嗪的合成及抗衰老活性。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines have been synthesized and screened for their in vitro and in vivo antileishmanial activity against Leishmania donovani. Among all, 14 compounds have shown promising inhibition of 80-100% at 10 microg/ml against promastigotes and IC(50) in the range of 0.89-9.68 microg/ml against amastigotes. Three compounds 13, 32 and 33 with good selectivity index (S.I.) were screened for their in vivo activity in golden hamsters (Mesocricetus auratus) infected with MHOM/IN/80/Dd(8) strain of L. donovani and have shown moderate in vivo inhibition of 48-56% at a dose of 50 mg/kg x 5, i.p. route for 5 days.
机译:已经合成了一系列的2,4,6-三取代的嘧啶和1,3,5-三嗪,并对其在体外和体内对利什曼原虫的杀螨活性进行了筛选。在所有化合物中,有14种化合物对前鞭毛体显示出有希望的抑制作用,对前鞭毛体的抑制作用为10微克/毫升,抑制80%至100%;对变形虫而言,IC(50)的抑制率为0.89-9.68微克/毫升。筛选了三种具有良好选择性指数(SI)的化合物13、32和33的体内活性,这些化合物在感染了多诺尼乳杆菌MHOM / IN / 80 / Dd(8)的金仓鼠(Mesocricetus auratus)中显示适中剂量为50 mg / kg x 5时,体内抑制48-56%路线持续5天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号